The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Blood Collection System
CP2D/AS-3 triple with sampling system · DEXTROSE, UNSPECIFIED FORM 3.57 g/70mL · Solution · Intravenous · Gvs Tm Inc
NDC 87069-0121-63 · 8 POUCH in 1 CARTON / 3 BAG in 1 POUCH / 70 mL in 1 BAG · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- BN820915
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of CP2D/AS-3 triple with sampling system (Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Gvs Tm Inc | DEXTROSE, UNSPECIFIED FORM 3.57 g/70mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Blood Collection System — NDC 87069-0121-63," retrieved September 3, 2026, https://drugdashboards.com/drug/87069012163.
Free to cite with attribution — see how the data is put together.